Rentokil Initial (NYSE:RTO) Shares Gap Up - Here's Why

Key Points

• Rentokil Initial shares jumped, opening at $22.39 versus a prior close of $21.04, and last traded near $22.61.
• Analyst sentiment remains mixed: the stock has a consensus “Hold” rating and a $31.90 average price target, with recent upgrades and downgrades from major firms.
• The company reduced its dividend to $0.224 per share from $0.412, while institutional investors made several purchases; institutions own approximately 9.91% of the stock.

Rentokil Initial PLC (NYSE:RTO - Get Free Report)'s share price gapped up prior to trading on Thursday. The stock had previously closed at $21.04, but opened at $22.39. Rentokil Initial shares last traded at $22.6090, with a volume of 471,471 shares changing hands.

Analysts Set New Price Targets

Several analysts have weighed in on RTO shares. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Rentokil Initial in a research note on Monday, August 3rd. Wall Street Zen downgraded Rentokil Initial from a "buy" rating to a "hold" rating in a research report on Monday, July 20th. The Goldman Sachs Group restated a "buy" rating on shares of Rentokil Initial in a research report on Monday, October 5th. BNP Paribas Exane cut Rentokil Initial from an "outperform" rating to a "neutral" rating and set a $26.70 price target on the stock. in a report on Friday, July 31st. Finally, Stifel Nicolaus upgraded Rentokil Initial from a "hold" rating to a "buy" rating in a report on Monday, October 5th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $31.90.

Rentokil Initial Price Performance

The firm's 50 day moving average price is $22.00 and its two-hundred day moving average price is $27.43. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.06 and a quick ratio of 0.98.

Rentokil Initial Cuts Dividend

The company also recently declared a dividend, which was paid on Tuesday, September 22nd. Investors of record on Friday, August 14th were paid a dividend of $0.2240 per share. This is a decrease from Rentokil Initial's previous dividend of $0.4120. The ex-dividend date of this dividend was Friday, August 14th. This represents a yield of 188.0%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. V Square Quantitative Management LLC lifted its position in Rentokil Initial by 84.5% in the 1st quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company's stock valued at $44,000 after acquiring an additional 639 shares in the last quarter. Continuum Advisory LLC bought a new position in Rentokil Initial in the 2nd quarter valued at $42,000. Integrated Wealth Concepts LLC bought a new position in Rentokil Initial in the 2nd quarter valued at $57,000. Parallel Advisors LLC increased its position in shares of Rentokil Initial by 50.5% during the 1st quarter. Parallel Advisors LLC now owns 2,107 shares of the company's stock valued at $66,000 after purchasing an additional 707 shares during the last quarter. Finally, Fifth Third Bancorp purchased a new stake in shares of Rentokil Initial during the 1st quarter valued at $83,000. 9.91% of the stock is owned by institutional investors.

About Rentokil Initial

Rentokil Initial plc NYSE: RTO is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.

The company's pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.